Sekiya Sachiko, Shimizu Tatsuya
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666 Japan.
Inflamm Regen. 2017 Dec 1;37:25. doi: 10.1186/s41232-017-0055-4. eCollection 2017.
With recent developments in tissue engineering technology, various three-dimensional tissues can be generated now. However, as the tissue thickness increases due to three-dimensionalization, it is difficult to increase the tissue scale without introduction of blood vessels.
Many methods for vasculature induction have been reported recently. In this review, we introduced several methods which are adjustable vascularization in three-dimensional tissues according to three steps. First, "selection" provides potents for engineered tissues with vascularization ability. Second, "assembly technology" is used to fabricate tissues as three-dimensional structures and simultaneously inner neo-vasculature. Third, a "perfusion" technique is used for maturation of blood vessels in three-dimensional tissues. In "selection", selection of cells and materials gives the ability to promote angiogenesis in three-dimensional tissues. During the cell assembly step, cell sheet engineering, nanofilm coating technology, and three-dimensional printing technology could be used to produce vascularized three-dimensional tissues. Perfusion techniques to perfuse blood or cell culture medium throughout three-dimensional tissues with a unified inlet and outlet could induce functional blood vessels within retransplantable three-dimensional tissues. Combination of each step technology allows simulation of perivascular microenvironments in target tissues and drive vascularization in three-dimensional tissues.
The biomimetic microenvironment of target tissues will induce adequate cell-cell interaction, distance, cell morphology, and function within tissues. It could be accelerated for vascularization within three-dimensional tissues and give us the functional tissues. Since vascularized three-dimensional tissues are highly functional, they are expected to contribute to the development of regenerative medicine and drug safety tests for drug discovery in the future.
随着组织工程技术的最新发展,现在可以生成各种三维组织。然而,由于三维化导致组织厚度增加,在不引入血管的情况下增加组织规模是困难的。
最近报道了许多诱导血管生成的方法。在本综述中,我们根据三个步骤介绍了几种可调节三维组织血管化的方法。首先,“选择”为具有血管化能力的工程组织提供潜能。其次,“组装技术”用于将组织制作为三维结构并同时形成内部新血管。第三,“灌注”技术用于三维组织中血管的成熟。在“选择”过程中,细胞和材料的选择赋予了促进三维组织中血管生成的能力。在细胞组装步骤中,细胞片工程、纳米膜涂层技术和三维打印技术可用于生产血管化三维组织。通过统一的入口和出口将血液或细胞培养基灌注到整个三维组织中的灌注技术可在可再移植的三维组织内诱导功能性血管。每个步骤技术的组合允许模拟目标组织中的血管周围微环境并驱动三维组织中的血管化。
目标组织的仿生微环境将诱导组织内充分的细胞间相互作用、距离、细胞形态和功能。它可以加速三维组织内的血管化并为我们提供功能性组织。由于血管化三维组织具有高度功能性,预计它们将有助于未来再生医学的发展和药物发现的药物安全性测试。